Beleaguered Wockhardt’s Regulatory Hurdles Increase With Second FDA Import Ban

Drug Industry Daily
A A
The FDA Tuesday hit Wockhardt with a second “import alert,” banning drug products from its Chikalthana plant in western India — the latest in a spate of regulatory actions taken against the struggling drugmaker.

To View This Article:

Login

Subscribe To Drug Industry Daily